AYTU Stock Analysis: Buy, Sell, or Hold?
AYTU - AYTU BioPharma, Inc. Common Stock
$2.60
0.02 (0.78%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When AYTU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AYTU shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: AYTU shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: AYTU is currently trading at $2.60, which is considered slightly low relative to its 30-day fair value range of $2.55 to $2.75. The stock's valuation (Forward PE: 15.2) is in line with its historical norms (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AYTU is in a uptrend. Immediate support is located at $2.45, while resistance sits at $2.85.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.33 (+261.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AYTU is in a uptrend. Immediate support is located at $2.45, while resistance sits at $2.85.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.33 (+261.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$2.55 -
$2.75
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 261.8% below Wall St target ($9.33)
Fair Price Analysis
30-Day Fair Range
$2.55 -
$2.75
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.45
Resistance Level
$2.85
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
15.18
Wall Street Target
$9.33
(+261.8%)
Revenue Growth (YoY)
-16.2%
Profit Margin
-20.5%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
15.2 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$2.54
(-2%)
2-Year Target
$2.50
(-3%)
3-Year Target
$2.47
(-4%)
3-Yr Target (if PE normalizes)
(PE: 15→16)
$2.58
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.2 to 15.9
Stabilization Target:
$2.70
(+4.8%)
PE Expansion Potential:
+4.8%
Last updated: January 31, 2026 4:35 AM ET
Data refreshes hourly during market hours. Next update: 5:35 AM
Data refreshes hourly during market hours. Next update: 5:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AYTU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced AYTU Option Strategies
Professional options setups generated by AI based on today's AYTU price and gamma walls.
